Le Lézard
Classified in: Health, Science and technology
Subject: FDA

Human Xtensions Receives FDA Clearance for Its HandX, the First in a Line of Smart Digital Handtop Solutions


NETANYA, Israel, March 22, 2018 /PRNewswire/ --

Human Xtensions, a rapidly growing startup company that develops handheld digital solutions for minimally invasive surgery (MIS), announces today that they received FDA 510 (k) clearance for HandXtm.

The smart, electromechanically-simplified surgical systems by Human Xtensions integrate all the components required for a modular platform, of which HandX is the first to be launched and be FDA cleared. HandX is designed as a light-weight, hand-held device that translates the surgeon's natural hand motions into complex movements inside the patient.

During MIS, Human Xtensions smart 5mm surgical tools pass through trocars, making much more possible in each MIS procedure, both in terms of access and natural freedom of movement. This also opens vast new horizons for converting open surgery into MIS, which expedites patient recovery and drastically improves outcomes. Moreover, the HandX is suited for any skill level, and offers hospitals of all sizes an affordable cost-effective alternative to the heavyweight robotic systems that are operated remotely.

Dr. Tami Frenkel, Co-Founder, Chairman, and CEO of Human Xtensions: "We believe in technology that gives virtuosic capacity to surgeons. The HandX demonstrates Human Xtensions' commitment to driving the art of surgery into new frontiers. We are proud to develop solutions that open a new era in surgery, and to serve as the company on the horizon that offers smart multifunctional handheld platforms, suited for a wide range of MIS. By creating technology that is transparent and personalized for each surgeon, surgical teams can now refocus on their patients and on the procedure at hand. Human Xtensions strives to give surgeons the advanced ecosystem they need for taking a giant leap forward, into artefficient surgery."

About Human Xtensions

Human Xtensions is a medical device company, focusing on reinventing minimal invasive surgery (MIS) with disruptive handtop technology. Founded in 2012 with the vision of making MIS a smart art, Human Xtensions is headquartered in Israel and led by a multidisciplinary team of professionals that bring the best of all worlds, from medicine to technology, and from ergonomics to design. Human Xtensions catalyzes an entirely new medical reality called Artefficient Surgery, with personalized digital platforms that combine the power of surgical robotics with the ease and affordability of hand-held solutions.

For more information:
Hillegonda Honny Groen
+972-546-284-449
[email protected]
human-x.com

SOURCE Human Xtensions


These press releases may also interest you

at 08:15
Blue Yonder, a leader in digital supply chain transformations, continues its forward momentum to revolutionize the supply chain and has today announced the signing of an agreement to acquire One Network Enterprises (One Network) for approximately...

at 08:13
In a significant move to address the heating and cooling needs of European families, Midea's Residential Air Conditioner Division (Midea RAC) unveiled its new CirQHP Family products at the Mostra Convegno Expocomfort (MCE) 2024. The CirQHP Family is...

at 08:00
Bidpath Inc., a leading provider of global online auction software, proudly announces the launch of AuctionPay, a cutting-edge payments platform designed to revolutionize auction payments. With a focus on efficiency, security, and user-centric...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
SC Ventures, Standard Chartered's innovation, fintech investment and ventures arm, is leading a ?12 million (USD $13 million) Series A round for distributed cloud provider Hive, to increase access to sustainable, high-powered computing resources for...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...



News published on and distributed by: